Veterinary Medicines

Vanguard CPV-Lepto

Authorised
  • Canine parvovirus, strain NL-35-D, Live
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
Download as PDF

Product identification

Medicine name:
Vanguard CPV-Lepto
Active substance:
  • Canine parvovirus, strain NL-35-D, Live
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain NL-35-D, Live
    8.50
    log10 cell culture infective dose 50
    /
    1.00
    Vial
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
    422.00
    unit(s)
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
    493.00
    unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI05
Legal status of supply:
  • Medicinal product subject to medical prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Blister met 25 glazen (Type I) injectieflacons met rubberstop en metalen felscapsule à 1 dosis vaccin.
  • Blister met 100 glazen (Type I) injectieflacons met rubberstop en metalen felscapsule à 1 dosis vaccin.
  • Blister met 10 glazen (Type I) injectieflacons met rubberstop en metalen felscapsule à 1 dosis vaccin.
  • Blister met 1 glazen (Type I) injectieflacon met rubberstop en metalen felscapsule à 1 dosis vaccin.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Zoetis B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • MEB
Authorisation number:
  • REG NL 8371
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 29/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."